Pallas Capital Advisors »

Allogene Therapeutics shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $18k 13k 1.37

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Microsoft Corporation (MSFT)
Global Partners Com Units (GLP)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Fundamental Intl (FNDF)
Dimensional Etf Trust Internatnal Val (DFIV)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Covington Trust Enhanced Intl (FENI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Pallas Capital Advisors

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Allogene Therapeutics